CROI 2014: Heart Attack Risk May Be Falling for People with HIV -- But Not for Women
- Details
- Category: Cardiovascular Disease
- Published on Friday, 14 March 2014 00:00
- Written by Gus Cairns
A number of studies at last week’s 21st Conference on Retroviruses and Opportunistic Infections in Boston examined whether people with HIV have an elevated risk of heart attack and other manifestations of cardiovascular disease (CVD). They came to different conclusions about whether having HIV is in itself a cardiovascular risk factor.
Coverage of the 2014 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Sunday, 09 March 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014), March 3-6, 2014, in Boston.
Conference highlights include new treatments for hepatitis C, HIV experimental therapies and treatment strategies, HIV cure research, HIV-related conditions, treatment as prevention and PrEP, and HIV/HCV coinfection.
Selected presentations and slide webcasts
3/9/14
CROI 2014: Retrovirus Conference Now Underway in Boston
- Details
- Category: HIV Treatment
- Published on Monday, 03 March 2014 00:00
- Written by Liz Highleyman
The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) kicked off in Boston this week with a program for young investigators, a press conference on new hepatitis C treatments, and opening lectures on HIV immune response and cross-species transmission and an update on the epidemic in West Africa.
HIVandHepatitis.com will be on site all week bringing you the latest news.
Coverage of the 2014 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Sunday, 09 March 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 21st Conference on Retroviruses and Opportunistic infections (CROI 2014), March 3-6, 2014, in Boston.
Conference highlights include new treatments for hepatitis C, HIV experimental therapies and treatment strategies, HIV cure research, HIV-related conditions, treatment as prevention and PrEP, and HIV/HCV coinfection.
Full HIVandHepatitis.com coverage by topic
Selected presentations and slide webcasts
3/9/14
CROI 2014: The Role of Interferon in HIV Response [VIDEO]
- Details
- Category: HIV Treatment
- Published on Monday, 03 March 2014 00:00
- Written by Gregory Fowler
Although interferon is on its way out as a standard of care for hepatitis C, researchers are learning more about its role in HIV, conference vice chair Julie Overbaugh said at a media briefing on the opening day of the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this week in Boston.
CROI 2014: Depression and HIV are Risk Factors for Heart Failure Among Veterans
- Details
- Category: Cardiovascular Disease
- Published on Friday, 07 March 2014 00:00
- Written by Theo Smart
Both HIV infection and depression are independent risk factors for incident heart failure, and living with both HIV and depression multiplies the risk, according to an analysis of data from the Veterans Aging Cohort Study presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this week in Boston.
CROI 2014: Retrovirus Conference Starts Monday in Boston
- Details
- Category: HIV Treatment
- Published on Friday, 28 February 2014 00:00
- Written by HIVandHepatitis.com
The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) will take place next week, March 3-6, at the Hynes Convention Center in Boston. HIVandHepatitis.com will be on site all week to bring you the latest news coverage about HIV, hepatitis C, and related topics.
CROI 2014: Tesamorelin Growth-Hormone Releaser Reduces Liver Fat in People with HIV
- Details
- Category: Metabolic Problems
- Published on Friday, 07 March 2014 00:00
- Written by Theo Smart
Tesamorelin, a synthetic form of growth-hormone-releasing hormone (GHRH), which the FDA has approved to reduce excess visceral abdominal fat in people living with HIV, also reduced associated liver fat in an HIV positive cohort chosen for abdominal adiposity, according to the results from a randomized, placebo-controlled trial presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this week in Boston.
Adolescents Born with HIV May Have Higher Heart Disease Risk
- Details
- Category: Cardiovascular Disease
- Published on Friday, 28 February 2014 00:00
- Written by NIH
Nearly half of adolescents with lifelong HIV infection were found to have evidence of coronary artery atherosclerosis, putting them at elevated risk for cardiovascular disease, according to a study published in the December 23, 2013, advance edition of Circulation.
More Articles...
- Cancer Is a Growing Concern Among People with HIV
- Low CD4 Count Raises Risk of Heart Attack, Bone Loss
- HIV Infection Linked to Structural Heart Disease
- HIV Medicine Association Guidelines Emphasize Primary Care Needs of People with HIV on ART
- Updated Pediatric HIV Opportunistic Infection Guidelines Emphasize Antiretroviral Therapy